Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Myeloid leukemia therapeutics market research report evaluates the therapeutics market of acute myeloid leukemia in G8 countries with respect to the current and pipeline drugs and regimens.

Chronic lymphocytic leukemia therapeutics market research report evaluates evaluates the market in G8 countries with respect to the current and pipeline drugs, regimens, analyzes geography; forecasting revenue, and trends.

Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)

[333 Pages Report] European Injectable Drug Delivery Market report categorizes the europe market by Therapeutics [Diabetes & Oncology], by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles], Market & Geography

Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landscape & Forecast to 2017

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

[Price: $4650] [No of Slides - 140] Browse 11 tables and 44 figures/charts on Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

[No of Slides - 140] Browse 11 tables and 44 figures/charts on Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

[Price: $4650] [No of pages - 280 ] Browse 130 market tables and 28 figures/charts on North America Injectable Drug Delivery Market report categories North America market estimating and forecasting 2017 by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles], Therapeutics [Diabetes & Oncology]& Geography

Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

[148 Slides] Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

[171 Slides Report] Aptamers Market categories the global market By Applications - Biosensors , Biomarker Discovery , Therapeutics , Diagnostics, Drug Discovery, by Technology Trends & by Geography

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018

European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017

Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

[261 Slides Report] Disposable Medical Devices Sensors Market categories the Global Market by Type [Biosensor, Accelerometer, Image sensor] Monitoring [Pulse Oximeter, Smart Pill] Diagnostic [Capsule Endoscope, Blood Glucose Strip] Therapeutic [Dialysis, Insulin pump] & by Geography

Sildalis is mainly used to overcome the problem of penile failure or impotence in males. Generic Tadalafil and Sildenafil are the main active therapeutic agents found in this tablet.

If you are feeling difficulty in achieving a proper penile erection, so you can try Suhagra 50mg, it will positively assist you. Generic Sildenafil is a main active constituent which inhibits the therapeutic action of PDE type-5 enzyme and causes an inflexible erection.